Intravenous Immunoglobulin (IVIG) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Intravenous Immunoglobulin (IVIG) Market was valued at $8,995 million in 2020, and is projected to reach $15,964 million by 2028, registering a CAGR of 7% from 2022 to 2028. 

Immunoglobulins are glycoproteins often produced in plasma that respond to antigens present in the body. Intravenous immunoglobulin is a blood product prepared from the serum of approximately 1,000 to 10,000 donors per batch. This type of treatment is used to treat people with antibody deficiency. Significant increase in the global geriatric population, increasing number of patients with hemophilia, and improved technology for high production of intravenous immunoglobulin and improved purification technology are key factors driving the global intravenous immunoglobulin market. However, stringent government regulations related to the use of intravenous immunoglobulins due to their harmful side effects could hamper the global market.

Market Segments

By Application

• Hypogammaglobulinemia
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Immunodeficiency Disease
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Idiopathic Thrombocytopenic Purpura (ITP)
• Inflammatory Myopathies
• Specific Antibody Deficiency
• Guillain–Barré Syndrome
• Others

By Type

• IgG
• IgA
• IgM
• IgE
• IgD

Key Players

ADMA Biologics, Inc., Shire plc, CSL Behring LLC, China Biologic Products, Inc., Kedrion S.p.A., Grifols S.A., Octapharma AG, Sanquin Plasma Products B.V., and LFB Biomedicaments S.A. are some of the key players working in the global intravenous immunoglobulin (IVIG) market. 

Scope of the Report

The research study analyzes the global Intravenous Immunoglobulin (IVIG) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Intravenous Immunoglobulin (IVIG) Market Report

1. What was the Intravenous Immunoglobulin (IVIG) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Intravenous Immunoglobulin (IVIG) Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Intravenous Immunoglobulin (IVIG) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.